Adverse effects of homeopathy: a systematic review of published case reports and case series
|
|
|
- Winifred Russell
- 10 years ago
- Views:
Transcription
1 SYSTEMATIC REVIEW Adverse effects homeopathy: a systematic review published case s and case P. Posadzki, A. Alotaibi, E. Ernst Complementary Medicine, Peninsula Medical School, Exeter, UK Correspondence to: Paul Posadzki, Complementary Medicine, Peninsula Medical School, Veysey Building, Exeter EX2 4SG, UK Tel.: +44 (0) Fax: +44 (0) [email protected] Disclosure None. SUMMARY Aim: The aim this systematic review was to critically evaluate the evidence regarding the adverse effects (AEs) homeopathy. Method: Five electronic databases were searched to identify all relevant case s and case. Results: In total, 38 primary s met our inclusion criteria. Of those, 30 pertained to direct AEs homeopathic remedies; and eight were related to AEs caused by the substitution conventional medicine with homeopathy. The total number who experienced AEs homeopathy amounted to Overall, AEs ranged from mild-to-severe and included four fatalities. The most common AEs were allergic reactions and intoxications. Rhus toxidendron was the most frequently implicated homeopathic remedy. Conclusion: Homeopathy has the potential to harm and consumers in both direct and indirect ways. Clinicians should be aware its risks and advise their accordingly. Review criteria We included all case s and case homeopathic remedies to treat human suffering from any type clinical condition using 5 databases from their inception to January 2012, without language restrictions. Message for the clinic Homeopathy is one the most commonly used type complementary medicine. It is utilized for a wide variety clinical conditions. Its safety has not been critically evaluated so far. The current evidence shows that homeopathy is not as innocent as it seems. It sometimes can lead to serious adverse events. Introduction Homeopathy can be defined as a therapeutic method that ten uses highly diluted preparations substances whose effects when administered to healthy subjects correspond to the manifestation the disorder (symptoms, clinical signs and pathological states) in the unwell patient (1). It is one the most popular form complementary and alternative medicine in the UK and elsewhere (2). The reasons for this widespread use are probably complex, but the assumption that homeopathy is safe is certainly an important factor (1). Although most homeopathic remedies are highly diluted, direct adverse effects (AEs) have been ed (3). Indirect risks mainly relate to replacing effective conventional treatments with ineffective homeopathic preparations (3,4). The aim this systematic review was to provide a summary and critical evaluation the published evidence regarding direct and indirect AEs associated with homeopathy. Method Electronic literature searches were conducted in January 2012 to identify case (CS) and case s (CR) AEs associated with homeopathy in human. The following electronic databases were used: MEDLINE, EMBASE, AMED, CINHAL and ISI. Details the search strategy are presented in the Appendix. In addition, our own extensive department files were hand-searched for further articles. No restrictions language or time publication were imposed. To be included, CS or CR had to pertain to AEs associated with the use any type homeopathic treatment in human. Data from spontaneous ing systems were included as well. We also included s where harm was not because a homeopathic remedy, but was associated with the use homeopathy as a replacement conventional treatments. Information from the included CS or CRs were extracted according to predefined criteria and assessed by two independent reviewers. Causality was estimated based on the description provided by the authors the primary articles. Any disagreements were settled through discussion. Results Our searches generated 378 articles, which 340 had to be excluded (Figure 1). Thus, 35 s met our eligibility criteria (5 40). Table 1 summarises direct AEs associated with the use homeopathy. Table 2 presents indirect AEs related to the substitution conventional care with homeopathy doi: /ijcp.12026
2 The safety homeopathy 1179 Total number hits for electronic search (n = 378) Additional records identified through manual search (n = 0) Duplicates removed (n = 157) Records screened (n = 221 ) Excluded: not CR or CS (n = 69) Full-text articles assessed for eligibility (n = 152) Excluded: no AEs (n = 114) Total number articles included: (n = 38) Figure 1 Flow diagram The total number amounted to 1159 ( those 1142 AEs were classified as direct and 17 as indirect AEs). The included articles originated from Austria, (5) Belgium, (20,31) Brazil, (16) Denmark, (23) France, (10,13,15) Germany, (36,38,40) Holland, (37) India, (32) Ireland, (18) Israel, (9,17,26) Italy, (11) Mexico, (29) Spain, (6,8,33) Sweden,(19) Switzerland, (25,39) UK(21,28) and the US (14,22,24). They were published between 1978 and The implicated homeopathic remedies included Aconitum 1000, AKO-PLEX, Arsenic Bromide 1-X, Arsenicum Sulfuratum Flavum-1-X, Baryta carbonica, BHI Regeneration Tablets, calcium carbonicum, Cantharis 1000, caesium chloride, chromium, Forte Saponaria, Gambogia, Gali-col Baby, hypericum perforatuma, Ipecacuanha, iron, Kalium Bichromicum, Ledum Palustre, Lilium Compositum, Loco X112, Lycopodium, Malaria Officinalis, Mercurius Heel Ò S, Mercurius 6a, Mercurius Sublimatus Corrosivus, Nat Mur 200, Notakehl, Nux Vomica, OT-10 and Penicillium Chrysogenum, Pentackan Sinnabaum, Petroleum D-5, Peruvian bark, Pulsatilla, Rhododendron Ferrugineum, Rhus Toxicodendron, Ruta Graveolens, Sedativ PC, Slenderness Drops, Solanum Compositum, sulphur, tanacetum, thuja, tuberculinum or unspecified homeopathic remedies. Direct AEs included abdominal pain, flatulence, acute erythroderma, acute pancreatitis, severe allergic reactions, atopic dermatitis, burning lips, nausea, emesis, apnoea, cyanosis, regurgitation, anaphylaxis, arsenical keratosis and cancer, bladder cancer, bullous pemphigoid, severe asthenia, cardiac arrest, cognitive-behavioural disorders, coma, death, dermatitis, severe pulmonary involvement, emesis, euphoria, extreme agitation, hyponatraemia and hypoalbuminaemia, erythaema, limb oedema, irritability and albuminuria, melanosis and keratosis, skin lesions, acute gastrointestinal illness, leukopaenia, thrombocytopaenia, diffuse dermal melanosis, metabolic acidosis, weight loss, chronic diarrhoea, morbiliform and pruritic rash with hospital admission, multiple alopecia and hair loss, pain, pancreatitis, problem with balance, somnolence, pruritus, swelling and erythroderma, renal failure with metabolic acidosis, interstitial nephritis and hyperkalaemia, severe acute tubulointerstinal nephritis, severe bradycardia, reversible panconduction defect, hypotension and syncope, severe swelling, bleeding, rashes, sneezing, rhinitis, slight lethargy, symptoms thall poisoning, tachypnea, high fever, lower limb areflexia, hypotension, pupillary abnormalities, gait ataxia, widespread leukocytosis and widespread maculopapular vesicular rash. Direct AEs homeopathy occasionally resulted in serious outcomes including cancer, death, dialysis, toxic polyneuropathy and quadriparesis. In several instances, presenting AEs required hospital admission (7,14,18,19,24) and pharmacotherapy (5,18,29,35,36). Indirect AEs included deterioration pulmonary allergy, deterioration sarcoidosis glomerulonephritis, hypertensive heart failure and encephalopathy, haemophilus influenzae meningitis, septicaemia high fever and seizures, malignant melanoma, multiple organ system failure, oedema, pneumococcal pneumonia with purulent pericarditis and coma, sepsis and death and severe aggravation atopic dermatitis. Indirect AEs homeopathy resulted in the following clinical outcomes: death, permanent hyper-
3 1180 The safety homeopathy Table 1 and case s AEs directly related to homeopathy treatment Adverse event Aberer (1991) (5) Audicana (2001) (6) Aviner (2010) (7) 3 C.1. Peruvian bark and Ipecacuanha (D4) C.2. Unspecified slenderness drops (n.m.) C.3. Unspecified mixture grass pollen (n.m.) 1 Mercurius Heel Ò S containing Mercurius solubilis Hahnemanni (D10), Hepar sulfuris (D8), Lachesis (D12), Phytolacca (D4), Ailanthus glandulosa (D3), Echinacea angustifolia (D3), Belladonna (D4) 11 Gali-col Baby containing Phosphorica, bryonia, Nux-vomica, Cuprum metallicum and Veratrum album (n.m.) n.m. C.1. Pruritus, swelling and erythroderma C.2. Morbiliform and pruritic rash C.3. Anaphylaxis Merbromin Widespread maculopapular vesicular rash n.m. ALTE including apnoea, cyanosis, regurgitation, flaccidity or vomiting Barquero,Romero (2004) (8) 1 Nux vomica and Rhus tox (n.m.) Glimepiride Acute pancreatitis, necrosis the pancreatic head Bernez (2008) (10) Cardinali (2004) (11) Chakraborti (2003) (12) 1 Sedativ PC (6 ingredients in 6CH) n.m. DRESS syndrome, severe pulmonary involvement 1 1. Rhus Toxicodendron mother tincture (alcohol solution) 2. Rhus Toxicodendron (7CH) 3 C.1.& C.3. Arsenic Bromide 1-X (n.m.) C.2. Arsenicum Sulfuratum Flavum-1-X (n.m.) n.m. Widespread dermatitis, leukocytosis n.m. C.1. Melanosis and keratosis, C.2. Skin lesions C.3.Acute gastrointestinal illness, leukopaenia, thrombocytopaenia and diffuse dermal melanosis Possible explanation Causality Treatment clinical outcome Allergic reactions* Almost certain C1 Anti-histamines. NFI. C2 Hospital admission. NFI C3 ICU admission. Adrenaline, steroids and intravenous fluid supplementation. NFI Allergic reaction mercury Almost certain Systemic corticosteroids and antihistamines Post-inflammatory hypopigmentation remained Overdosing, toxicity* Almost certain Hospital admission. Lumbar puncture, lactate, ammonia, ECG, EEG, brain sonography, gastrografin imaging, and echocardiogram. All fully recovered within 13 days Unclear Likely ICU admission. Respiratory distress, gastrointestinal bleeding and death after 2 weeks Hypersensitivity* Certain Full recovery Allergic reaction* Certain Full recovery Arsenic Almost certain C1-C2 Improvement on discontinuation C3 Toxic polyneuropathy and quadriparesis
4 The safety homeopathy 1181 Table 1 Continued Curry (2006) (14) Duque-Estrada (2009) (16) Farrell (1995) (18) Forsman (1991) (19) treatment Adverse event Possible explanation Causality Treatment clinical outcome 1 Caesium chloride (n.m.) Chemotherapy, anaesthetic agents, CoQ10, coral calcium, bovine colostrum, seal oil, multivitamin, vitamin D, 1 Injection Lilium compositum, Solanum compositum, Thuja, and Tanacetum (n.m.) 1 Oral Hypericum perforatuma and Ledum palustre (n.m.) 2 C.1. a. AKO-PLEX containing: Juglans (D6), Silicea (D12), Antimonium (D12), Arnica (D6), Sarsaparilla (D6), Daisies (D6), Mezereum (D6), Dulcamara (D6) b. Forte Saponaria containing: Gramin jugul., Rhamnus cath., Viola od., Cichor., Cent., Inula, Nastur., Sapon., Scroph. Bellis, Viola tr., Dulcam, Hydrocot, Mezer, Sarsap, Thuja (all at D6) c. OT 10 containing: Sennae, Frangula, Phaseoli, Mentha pip., Rubi, Fucus, Malvae, Taraxacum, Betula alba. C.2. Three different unspecified preparations (n.m.) Cardiac arrest Cesium or interactions with anaesthetic agents Likely Full recovery. NFI n.m. Hair loss Unclear* Almost certain Complete recovery after 7 months None Severe acute tubulointerstinal nephritis n.m. C.1. Atopic dermatitis C.2. Severe swelling, bleeding and rashes Unclear Likely Hospital admission. Hemodialysis and methylprednisone. Improved renal function after 14 days Allergic reaction* Likely in both cases C1 Hospital admission. Topical steroids and antihistamines. Full recovery within several months. C2 Hospital admission. NFI
5 1182 The safety homeopathy Table 1 Continued Geukens (2001)(20) Goodyear (1990) (21) Guha (1999) (22) Kerr (1986) (24) Kuenzli (2004) (25) Menniti-Ippolito (2008) (27) Monk (1986) (28) Montoya- Cabrera (1991) (29) Mortelmans (2004) (30) treatment Adverse event Possible explanation Causality Treatment clinical outcome 1 Aconitum 1000, Baryta carbonica, Cantharis 1000,Gambogia, Pulsatilla, Rhus tox (M and 10 M) 1 Nine different remedies, including iron and arsenic (both at 6 C) n.m. Heart disease and bladder cancer n.m. Hyponatraemia, hypoalbuminaemia, erythaema and limb oedema 1 Tincture aconite n.m. Severe bradycardia, reversible panconduction defect, hypotension and syncope 1 Regeneration Tablets- a mixture 19 ingredients (n.m.) 1 Topical and or oral calcium, sulphur, lycopodium, mercurius, cantharis, rhus toxicodendron, calcium carbonicum, sepia and tuberculinum (n.m.) 21 Various remedies-both mono and poly-preparations, including Kalium Bichromicum and Mercurius Sublimatus Corrosivus (from D1) n.m. Pancreatitis, pain, nausea, vomiting None Bullous pemphigoid, severe asthaenia Unclear Almost certain Radiotherapy. Full recovery Unclear* Almost certain Hospital admission. Sodium chloride solution, albumin infusions, intravenous flucloxacillin and benzylpenicillin, potassium permanganate baths, topical corticosteroids and antibiotics. Persistent mild eczema at 4 months follow up Aconitum Protoanemonin and saponic glycosides toxicity Mercury n.m. Allergic reactions Immune allergic reactions, hypersensitivity Almost certain Marked improvement in symptoms within a few hours Almost certain Hospital admission. Conservative treatment. Full recovery after 6 days Likely Oral prednisone and sulfapyridine. Rapid improvement within 2 weeks Likely n.r. 1 Injection Nat Mur 200 (n.m.) n.m. Acute erythroderma Unknown* Likely ICU admission. n.r. 1 Mercurius 6a (D6) n.m. Dermatitis, irritability and albuminuria 1 Loco X112 drops (n.m.) Alcohol and amphetamine Mercury Extreme agitation Interactions alcohol, thyroid extract free T3 and T4), diethylpropione, and amphetamine * and Almost certain D-penicillamine administration. Full recovery Likely Diazepam, propol. Full recovery
6 The safety homeopathy 1183 Table 1 Continued Potier (1998) (31) Prasad (2006) (32) Rodriguez-Vico (2009) (33) Sasseville (1995) (34) Stevens (1978) (35) Turkoglu-Raach (2010) (36) Van Ulsen (1988) (37) Von Mach (2006) (38) treatment Adverse event Possible explanation Causality Treatment clinical outcome 1 Unspecified remedies (n.m.) n.m. but with history depression, cholecystectomy, neurological and vascularaccidents. 1 Unspecified remedy (n.m.) n.m. but patient with a history neck swelling, cough, haemoptysis, shortness breath, fever and weight loss Coma Bromate Arsenical keratosis and cancer Arsenic 1 Petroleum (D5) Carbamazepine Tachypnoea, high fever, lower limb areflexia, hypotension, pupillary abnormalities, gait ataxia, cognitive-behavioural disorders 2 C.1. Ointment containing Rhus toxicodendron (2CH), Rhododendron ferrugineum (2 CH), Ruta graveolens (2 CH), Ledum palustre (2 CH) C.2. Ointment containing Rhus toxicodendron tincture 4.00 g History dermatitis Allergic dermatitis, perioral swelling and vesiculation 1 Unspecified remedy (n.m.) None Migraine, retrosternal oppression, paresthesias, pain, burning sensation, 1 Notakehl Ò containing Penicillium chrysogenum (D4) n.m. Renal failure with metabolic acidosis, interstitial nephritis and hyperkalaemia 1 Pentackan Sinnabaum (D4) n.m. Severe exacerbation eczaema with swelling 1070 Unspecified remedies (n.m.) n.m. Mostly mild symptoms (no details provided) Kerosene Likely Antibiotics, mucolytics and haemodialysis. Full recovery within 15 days Likely Hospital admission. Chemotherapy. Death Almost certain Hospital admission. Full recovery within 1-week Allergic reactions* Likely C1 Clobetasol 17-propionate. Full recovery within 2 weeks C2 Oral corticosteroids. Full recovery within 5 days Thall Likely Prussian blue and potassium chloride. Full recovery within 1-week Allergic reaction*and Likely Corticosteroids and hemodialysis. Full recovery Chromium Likely No improvement. Unclear* Unclear n.r.
7 1184 The safety homeopathy Table 1 Continued treatment Adverse event Possible explanation Causality Treatment clinical outcome Wille (2010) (39) Zuzak (2010) (40) 1 Xylitol containing homeopathic globules 9 C.1. C.2. Calendula ficinalis (mother tincture) C.3. Mater perlarum (D4) C.4. Allium cepa (D4 D15) C.5. C.6. Chamomile globules (n.m.) C.7. Bach flower rescue drops (n.m.) C.8. Chamomilla (D10), Mercurius (D15), sulphur (D12) C.9. Thujas (mother tincture) n.m. Severe metabolic acidosis, weight loss, chronic diarrhoea n.m. C.1. Sneezing, rhinitis; C.2. Slight lethargy; C.3. Emesis; C.4. euphoria; C.5. Abdominal pain, flatu lence; C.6. Emesis; C.7.Problem with balance, somnolence; C.8. Pain; C.9. Burning lips, nausea, emesis Enteral bicarbonate loss* Likely ICU admission. Full recovery after 3 months Unclear* Likely in all cases n.r. AEs, adverse effects; ALTE, apparent life-threatening event; DRESS, drug rash with eosinophilia and systemic symptoms; ECG, electrocardiogram; EEG, electroencephalogram; ICU, intensive care unit; NFI, no further information; n.r., not ed; SB, sinus bradycardia; TdP, torsades de pointes; VF, ventricular fibrillation; C, case. *As judged by the author primary. As judged by the present author.
8 The safety homeopathy 1185 Table 2 and case s AEs related to substitution conventional care with homeopathy treatment Condition Possible explanation Causality Treatment clinical outcome Benmeir (1991) (9) Colin (2006) (13) Delaunay (2000)(15) Edelson (1999) (17) Forsman (1991) (19) Ibsen (1987) (23) Lim (2011) (41) Luder (2000) (26) 1 Ointment and unspecified remedies (n.m.) 2 Lycopodium, Pulsatilla and Sulphur*(CH 15 and 30) 1 Ledum palustre (5CH) and Malaria ficinalis (4 CH) n.m. Malignant melanoma Negligence and lack CT,à Certain Surgery. Full recovery after 7 months n.m. Deterioration pulmonary allergy Unclearà Likely n.r. Conventional prophylactic drugs, NFI Multiple organ system failure Parasitaemia Certain ICU admission. Intensive care for 2 months. NFI 1 Unspecified remedy (n.m.) n.m. Deterioration sarcoidosis Discontinuation CT Almost certain 1 Unspecified ointment n.m. Malignant melanoma Delayed diagnosisà Likely Unknown 4 Unspecified remedies (n.m.) n.m. C.1. C.4. Severe aggravation atopic dermatitis 3 Unspecified remedies (n.m.) n.m. C.1. Malnutrition, sepsis and death C.2. Malnutrition and oedema C.3. Seizures 3 Unspecified remedies (n.m.) n.m. C.1. Pneumococcal pneumonia with purulent pericarditis and coma C.2. Glomerulonephritis, hypertensive heart failure and encephalopathy C.3. haemophilus influenzae meningitis, septicaemia high fever and seizures Hospital admission. Corticosteroids. NFI Discontinuation CTà Likely ICU admission. Full recovery Negligence and lack CT, à Negligence and lack CT, à Certain Hospital admission. NFI Certain C.1.Death C.2. Permanent hypertension C.3. Hydrocephalus and neuro-surgical drainage AEs, adverse effects; ICU, intensive care unit; CT, conventional treatment; NFI, no further information; n.m., not mentioned; C, case. *The most commonly used. As judged by the author primary. àas judged by the present author.
9 1186 The safety homeopathy tension, hydrocephalus and the need for neurosurgical drainage. The duration AEs ranged from a few hours (22) to 7 months (9,16). Eighteen experienced a full recovery (6,7,9 12,14,16,18,21 25,29 31,33,35, 36,39) and four died (8,26,32,41). In six cases, details AEs were insufficient for a judgment regarding cause and effect (13,19,27,28,34,37,38,40). In 17 cases, causality was deemed to be likely, certain in six, almost certain in 12 and unclear in one. The AEs were caused by allergic reactions, (5,6,8,11,19,27, 34,36,39) ingestion toxic substances (6,7,12,21,22, 24,25,29 33,35,37) and substitution conventional care (9,13,15,17,19,23,26,41). Discussion Our systematic review was aimed at summarising and critically evaluating the available evidence from CS and CR regarding AEs homeopathy in human. According to our findings, homeopathy can lead to AEs, some which are serious. A recent on the safety homeopathy by the European Council for Classical Homeopathy (ECCH) concluded that homeopathy is safe to use. However, this was incomplete and included only a third the CRs CS located by us for the present review (42). The ECCH also commented on the safety homeopathy relative to conventional treatments. It seems likely that homeopathic remedies cause far less and fewer AEs than conventional drugs, however, such a comparison might be misleading as not the absolute risk an intervention, but its risk-benefit balance would determine the value any medical treatment. If the benefit is small or non-existent, even a minute risk would tilt this balance into the negative. An audit the Bristol Homeopathic Hospital among 116 ed that 11% them experienced AEs, including headaches, lethargy or vomiting (43). This percentage figure is difficult to interpret as the authors categorise diarrhoea, eczaema, gastrointestinal upset, hair loss, infections, nausea, migraines, pains, rash, skin irritation, tension headaches, tiredness fatigue as homeopathic aggravations, new symptoms and or return old symptoms. Our own review the evidence for or against the existence homeopathic aggravations included 24 placebo-controlled trials ing aggravations, and we came to the conclusion that this systematic review does not provide clear evidence that homeopathic aggravations exist (44). In the majority cases, the possible mechanism action involved allergic reactions or ingestion toxic substances. Preparations heavy metals, such as arsenic, cadmium, mercury or iron, which are frequently used in homeopathy can be toxic, (45) if not highly diluted. Other poisons regularly employed in homeopathy include aconitum, kerosene or thallium, which also can lead to serious health problems in sufficiently low dilutions. We identified both direct and indirect AEs homeopathy. The former related to the homeopathic remedy itself and the latter predominantly referred to the replacement effective conventional therapies with ineffective homeopathic remedies. It was ten impossible to distinguish precisely between the two types AEs. The information whether a fully qualified and registered homeopath applied, the homeopathic remedy was frequently missing. Similarly, other valuable details were ten not included in the primary publications. In 94.7% cases, the potencies were described as below 12 C, the point beyond which the likelihood a single molecule being present in the remedy approaches zero. It is plausible that low dilutions homeopathic preparations cause direct AEs, particularly allergic reactions. One might argue that incidences classified as indirect AEs by us are not truly AEs homeopathy, but are the result less than competent healthcare. We have therefore tried to differentiate as clearly as possible between the two. One might also wonder why relatively few indirect AEs have been ed. Most experts view the use ineffective homeopathic treatments for serious conditions is potentially more harmful than the harm done by homeopathic remedies. One explanation could be that indirect harm this nature rarely gets ed.evidence indirect AEs highlight the need for all homeopaths to be adequately trained such that harm this nature can be avoided in future. The preference homeopathy over conventional medicine when dealing with serious, life-threatening conditions may cause serious harm, and this issue relates to the question practitioner training (15,17,26). The treatment cervical streptococcal lymphadenitis, acute lymphatic leukaemia, bacterial pneumonia and atopic dermatitis with homeopathic remedies is clearly dangerous (4,26,46) simply because homeopathy is not effective for any these conditions. Other examples serious conditions that have been treated homeopathically include anxiety, (47) depression, (48) eczema, (49) insomnia, (50) migraine prophylaxis and rheumatic conditions (51). The fact that such cases are being ed, albeit rarely, seems worrying. Again, we would therefore stress the need for making sure all homeopaths are medically competent. We were unable to extract the data from one article that combined homeopathy with other modalities, such as herbals and dietary supplements. e.g. (52); in this retrospective analysis cases, homeopathy had the second highest hospitalisation index with a total 255 AEs ed.
10 The safety homeopathy 1187 Our systematic review has several strengths; we conducted extensive literature searches, did not impose restrictions according to language or time publication, assessed the ed cases according to predefined criteria and tried to exclude bias where we could. We were able to include more AEs than any previous review has done. However, our systematic review also has a number important limitations. They pertain to the potential incompleteness the evidence. AEs homeopathy are likely to be undered; therefore, the number cases summarised herein is less meaningful than the fact that such incidents exist at all. The ten low quality the primary s further limits the conclusiveness our findings. Several s lacked sufficient detail, which renders the interpretation their findings problematic (13,15,23,27,28,34,37,38,40). Given such caveats, a cause-effect relationship between the homeopathy and the AEs was frequently difficult to establish. We did not include systematic reviews, clinical trials, surveys and cohort studies in our review.a systematic review the AEs homeopathy, concluded that the incidence AEs homeopathic remedies was greater than that placebo in controlled clinical trials; AEs included headache, tiredness, skin eruptions, dizziness, bowel dysfunctions and allergic reactions (53). Our review CR and CS is thus not comprehensive. Crucially, it does not tell us anything about the incidence AEs. Considering the widespread use homeopathy worldwide and the relative paucity the ed AEs, it might be very low. Collectively, these limitations render our review less conclusive than we had hoped. In conclusion, several s AEs homeopathy have been published and some AEs had serious consequences. Clinicians should be aware the risks associated with homeopathy. Acknowledgements PP has a fellowship from the Royal College Physicians, London. The RCP had no role in study, data collection and interpretation. PP would like to thank Pressor Yori Gidron for his translation the Hebrew article. Appendix: Detailed search strategy for medline 1 (homeop$ or homeop$ or homoop$).ti,ab,tw 2 Exp Homeopathy 3 (adrs or adr or complicat$ or aggravat$ or exacerbat$).ti,ab 4 (safe or safety or risk$ or harm$).ti,ab 5 Side effect$.ti,ab 6 (Adverse ADJ3 (effect$ or event$ or interaction$ or outcome$ or reaction$ or response$)).ti,ab 7 (Undesir$ ADJ3 (effect$ or event$ or interaction$ or outcome$ or reaction$ or response$)).ti,ab 8 (Unexpected ADJ3 (effect$ or event$ or interaction$ or outcome$ or reaction$ or response$)).ti,ab 9 (Uninten$ ADJ3 (effect$ or event$ or interaction$ or outcome$ or reaction$ or response$)).ti,ab 10 (Unwanted ADJ3 (effect$ or event$ or interaction$ or outcome$ or reaction$ or response$)).ti,ab 11 (Serious ADJ3 (effect$ or event$ or interaction$ or outcome$ or reaction$ or response$)).ti,ab 12 (tolerate or tolerability or tolerance or tolerant or hypersensativ$ or allerg$).ti,ab 13 (intolerate or intolerability or intolerance or intolerant).ti,ab 14 (toxic$ or toxin$ or intox$ or Poison$ or noxious or septic$ or hepatotoxic$ or phototoxic$ or nephrotoxic$ or carcinogenic$ or cardiotoxic$ or cytotoxic$ or Genotoxic$).ti,ab 15 (adulterat$ or contaminat$ or interact$ or pollut$).ti,ab 16 (Death$ or fatal$).ti,ab 17 (Overdose or Over-dose).ti,ab. 18 Aftereffect$.ti,ab 19 Reaction$.ti,ab 20 secondary respons$.ti,ab 21 chemically induced.ti,ab 22 Contraindication$.ti,ab 23 sequela$.ti,ab 24 (death ADJ3 sudden$).ti,ab 25 exp drug toxicity 26 Exp postmarketing surveillance 27 Exp Report$ 28 ($ Adj3 (stud$ or $ or histor$ or $ or record$)).ti,ab 29 1 or 2 AND 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 Reference 1 Ernst E, Pittler MH, Wider B, Boddy K. The Desktop Guide to Complementary and Alternative Medicine, 2nd edn. Edinburgh: Elsevier Mosby, Hunt K, Ernst E. Patients use CAM: results from the Health Survey for England Focus Altern Complement Ther 2010; 15: Ernst E. Risk-free homeopathy? Schweiz Med Wochenschr 1996; 126: Vickers A, Zollman C. ABC complementary medicine homoeopathy. BMJ 1999; 319: Aberer W, Strohal R. Homeopathic preparations severe adverse-effects, unproved benefits. Dermatologica 1991; 182: Audicana M, Bernedo N, Gonzalez I, Munoz D, Fernandez E, Gastaminza G. An unusual case baboon syndrome due to mercury present in a homeopathic medicine. Contact Dermatitis 2001; 45: Aviner S, Berkovitch M, Dalkian H, Braunstein R, Lomnicky Y, Schlesinger M. Use a homeopathic preparation for infantile colic and an apparent life-threatening event. Pediatrics 2010; 125: E Barquero RJ, Redondo Lopez JM, Galeano DF, Perez MM. [Fatal acute pancreatitis in a patient
11 1188 The safety homeopathy who received an homeopathic treatment]. [Spanish]. Med Clin 2004; 122:318 9.Mar 6. 9 Benmeir P, Neuman A, Weinberg A et al. Giant melanoma the inner thigh a homeopathic life-threatening negligence. Ann Plast Surg 1991; 27: Bernez A, Perrinaud A, bdallah-lotf M, Magro P, Machet L. [DRESS syndrome with severe pulmonary involvement following oral intake a homeopathic drug]. [French]. Ann Dermatol Venereol 2008; 135: Cardinali C, Francalanci S, Giomi B, Caproni M, Sertoli A, Fabbri F. Contact dermatitis from Rhus toxicodendron in a homeopathic remedy. J Am Acad Dermatol 2004; 50: Chakraborti D, Mukherjee SC, Saha KC, Chowdhury UK, Rahman MM, Sengupta MK. Arsenic toxicity from homeopathic treatment. J Toxicol Clin Toxicol 2003; 41: Colin P. Homeopathy and respiratory allergies: a 147 cases. Homeopathy 2006; 95: Curry TB, Gaver R, White RD. Acquired long QT syndrome and elective anesthesia in children. Pediatr Anesth 2006; 16: Delaunay P. Homoeopathy may not be effective in preventing malaria. BMJ 2000; 321: Duque-Estrada B, Vincenzi C, Misciali C, Tosti A. Alopecia secondary to mesotherapy. J Am Acad Dermatol 2009; 61: Edelson G, Levy Y, Shoenfeld Y. Relapse sarcoidosis after alternative medical treatment. Harefuah 1999; 136: Farrell J, Campbell E, Walshe JJ. Renal failure associated with alternative medical therapies. Ren Fail 1995; 17: Forsman S. Homeopati kan vara farling vid hudsjukdomar och allergier. Läkartidningen 1991; 88: Geukens A. Two more case histories. J Am Ins Homeopath 2001; 94: Goodyear H, Harper J. Atopic eczema, hyponatraemia, and hypoalbuminaemia. Arch Dis Child 1990; 65: Guha S, Dawn B, Dutta G, Chakraborty T, Pain S. Bradycardia, reversible panconduction defect and syncope following self-medication with a homeopathic medicine. Cardiology 1999; 91: Ibsen H, Halkier-Sørensen L, Thestrup-Pedersen K. Complications in with atopic dermatitis after use an alternative treatment. Ugeskr Laeger 1987; 149: Kerr HD, Yarborough GW. Pancreatitis following ingestion a homeopathic preparation. N Engl J Med 1986; 314: Kuenzli S, Grimaitre M, Krischer J, Saurat JH, Calza AM, Borradori L. Childhood bullous pemphigoid: a case with life-threatening course during homeopathy treatment. Pediatr Dermatol 2004; 21: Luder A, Frydman G. The mortality and morbidity non-medical ( Alternative ) treatment for minors. Int J Adolesc Med Health 2000; 12: Menniti-Ippolito F, Mazzanti G, Santuccio C et al. Surveillance suspected adverse reactions to natural health products in Italy. Pharmacoepidemiol Drug Saf 2008; 17: Monk B. Severe cutaneous reactions to alternative remedies. BMJ 1986; 293: Montoya-Cabrera MA, Rubio-Rodriguez S, Valazquez-Gonzalez E, Avila MS. Intoxicacion mercurial causada por un medicamento homeopatico. Gaceta Med Mex 1991; 127: Mortelmans LJM, Biesemans L, Van Rossom P. Homeopathic products, not as innocent and safe as they seem? A case. Eur J Emerg Med 2004; 11: Potier JP. Bromate intoxication due to the ingestion a dose prescribed by a homeopathist. Nephrol Dial Transplant 1998; 13: Prasad HRY, Malhotra AK, Hanna N et al. Arsenicosis from homeopathic medicines: a growing concern. Clin Exp Dermatol 2006; 31: Rodriguez-Vico JS, Martinez-Pueyo A, Mendoza- Rodriguez A, Duarte J. Neurological manifestations in accidental poisoning by homeopathic kerosene. Neurologia 2009; 24: Sasseville D, Nguyen K. Allergic contact dermatitis from Rhus toxicodendron in a phytotherapeutic preparation. Contact Dermatitis 1995; 32: Stevens W. Thallium intoxication caused by a homoeopathic preparation. Toxicol Eur Res 1978; 1: Turkoglu-Raach G, Grone HJ, Sitter T, Fischereder M. Another suspect : homeopathic agent associated with acute interstitial nephritis. Dtsch Med Wochenschr 2010; 135: Van Ulsen J, Stolz E, Joost T. Chromate dermatitis from a homoeopathic drug. Contact Derm 1988; 18: von Mach MA, Habermehl P, Zepp F, Weilemann LS. Drug poisonings in childhood at a regional poisons unit. Klin Padiatr 2006; 218: Wille D, Hauri-Hohl M, Vonbach P, Tomaske M, Padden B, Bernet V. Too much too little: xylitol, an unusual trigger a chronic metabolic hyperchloremic acidosis. Eur J Pediatr 2010; 169: Zuzak TJ, Rauber-Luthy C, Simoes-Wust AP. Accidental intakes remedies from complementary and alternative medicine in children-analysis data from the Swiss Toxicological Information Centre. Eur J Pediatr 2010; 169: Lim A, Cranswick N, South M. Adverse events associated with the use complementary and alternative medicine in children. Arch Dis Child 2011; 96: /ECCHSafetyReport_2009.pdf (accessed April 2012) Thompson E, Barron S, Spence D. A preliminary audit investigating remedy reactions including adverse events in routine homeopathic practice. Homeopathy 2004; 93: Grabia S, Ernst E. Homoeopathic aggravations: a systematic review randomised, placebo-controlled clinical trials. Homeopathy 2003; 92: Forth W. Potentiell toxische Schwermetalle als Therapeutikum in der Homóopathie. Deutsches Ärzteblatt 1996; 93: Tsur M. Inadvertent child health neglect by preference homeopathy to conventional medicine. Harefuah 1992; 122: Pilkington K, Kirkwood G, Rampes H, Fisher P, Richardson J. Homeopathy for anxiety and anxiety disorders: a systematic review the research. Homeopathy 2006; 95: Pilkington K, Kirkwood G, Rampes H, Fisher P, Richardson J. Homeopathy for depression: a systematic review the research evidence. Homeopathy 2005; 94: Ernst E. Homeopathy for eczema: a systematic review controlled clinical trials. Br J Dermatol 2012; 166: Cooper KL, Relton C. Homeopathy for insomnia: a systematic review research evidence. Sleep Med Rev 2010; 14: Ernst E. A systematic review systematic reviews homeopathy. Br J Clin Pharmacol 2002; 54: Vassilev ZP, Chu AF, Ruck B, Adams EH, Marcus SM. Evaluation adverse drug reactions ed to a poison control center between 2000 and Am J Health-Syst Pharm 2009; 66: Dantas F, Rampes H. Do homeopathic medicines provoke adverse effects? A systematic review. Br Homeopath J 2000; 89 (Suppl. I): S35 8. Paper received May 2012, accepted August 2012
Observational studies on homeopathy
Observational studies on homeopathy To healthcare providers, patients and clinicians, what matters most is not necessarily how well a treatment performs under the artificially controlled conditions on
Summary of the risk management plan (RMP) for Accofil (filgrastim)
EMA/475472/2014 Summary of the risk management plan (RMP) for Accofil (filgrastim) This is a summary of the risk management plan (RMP) for Accofil, which details the measures to be taken in order to ensure
Intravenous Methyl Prednisolone in Multiple Sclerosis
Intravenous Methyl Prednisolone in Multiple Sclerosis Exceptional healthcare, personally delivered Relapse management in multiple sclerosis Relapses in multiple sclerosis (MS) are common and caused by
Adverse Events Following Immunisation (AEFI) Noel McCarthy Thames Valley Public Health England Centre and Everybody
Adverse Events Following Immunisation (AEFI) Noel McCarthy Thames Valley Public Health England Centre and Everybody A fifteen year old with diabetes came for his MMR and was referred by the school nurse
2 months Diptheria; Tetanus; Whooping Cough; Hib & Polio 1st dose Pneumococcal Conjugate Vaccination
IMMUNISATIONS You may want to know if your child should have routine immunisations and whether there could be an increased risk of complications because of the heart condition. We have sought the opinions
PACKAGE LEAFLET: INFORMATION FOR THE USER. ADRENALINE (TARTRATE) STEROP 1 mg/1 ml Solution for injection. Adrenaline (Levorenine, Epinephrine)
PACKAGE LEAFLET: INFORMATION FOR THE USER ADRENALINE (TARTRATE) STEROP 1 mg/1 ml Solution for injection Adrenaline (Levorenine, Epinephrine) Read all of this leaflet carefully before you start using this
Homeopathy. Homeopathy is one of the more controversial forms of CAM. Much of. Treatment Method
Homeopathy Homeopathy is one of the more controversial forms of CAM. Much of the controversy is due to the fact that the basic principles of homeopathy are in conflict with many of the fundamental concepts
Homeopathy as a treatment for HIV and Aids in Swaziland
Homeopathy as a treatment for HIV and Aids in has been estimated to have the highest infection rateof HIV in the world. The demographics from the Homeopathy project database indicate the following: at
Adrenaline autoinjector (EpiPen) for acute allergic anaphylaxis
for acute allergic anaphylaxis This review of adrenaline autoinjector was first published in December 2003. This update describes the change to the PBS listing to allow prescribing immediately after hospital
Vitamins and Supplements for Cancer Survivors
Vitamins and Supplements for Cancer Survivors Moving Beyond Cancer to Wellness Fred Hutchinson Cancer Research Center Dan Labriola ND Lisa Price ND Tara Stacker ND Carrie Dennett RD, MPH Northwest Natural
Factsheet September 2012. Pertussis immunisation for pregnant women. Introduction
Factsheet September 2012 Pertussis immunisation for pregnant women Introduction The routine childhood immunisation programme has been very effective in reducing the overall numbers of cases of pertussis.
National Cancer Institution (NCI) Toxicity Criteria
National Cancer Institution (NCI) Toxicity Criteria Toxicity Grade 0 1 2 3 4 Blood/Bone Marrow WBC?4.0 3.0-3.9 2.0-2.9 1.0-1.9
Many people with MS use some form of conventional medical treatment, and many people also use complementary and alternative medicine (CAM).
Complementary and alternative medicine (CAM) CAM therapies can generally be divided into the following categories: Biologically based therapies (eg, dietary supplements, diets, bee venom therapy, hyperbaric
HOMEOPATHY AS AN ALTERNATIVE TO ANTIBIOTICS
HOMEOPATHY AS AN ALTERNATIVE TO ANTIBIOTICS Professor Dr. Michael FRASS Medical University of Vienna, Department Medicine I Doctor s Asscociation for Classical Homeopathy www.aekh.at President, Umbrella
Benzodiazepines. And Sleeping Pills. Psychological Medicine
Benzodiazepines And Sleeping Pills Psychological Medicine Introduction Benzodiazepines are a type of medication prescribed by doctors for its therapeutic actions in various conditions such as stress and
Trileptal (Oxcarbazepine)
Brand and Generic Names: Trileptal Tablets: 150mg, 300mg, 600mg Liquid Suspension: 300mg/5mL Generic name: oxcarbazepine What is Trileptal and what does it treat? Trileptal (Oxcarbazepine) Oxcarbazepine
Protecting your baby against meningitis and septicaemia
Protecting your baby against meningitis and septicaemia caused by meningococcal B bacteria MenB vaccine now available! Information about the MenB vaccine and recommended paracetamol use mmunisation The
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT
BOTOX Treatment. for Chronic Migraine. Information for patients and their families. Botulinum Toxin Type A
BOTOX Treatment Botulinum Toxin Type A for Chronic Migraine Information for patients and their families. Is Chronic Migraine the same as Migraine? Chronic Migraine is similar to migraine as sufferers experience
patient group direction
DICLOFENAC v01 1/8 DICLOFENAC PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner
Things You Should Know About Adverse Event Report Data
U.S. Department of Health and Human Services Food and Drug Administration Center for Food Safety and Applied Nutrition CFSAN Adverse Event Reporting System Voluntary Reports on Red Bull Energy Drink January
Paracetamol apollo +9191 46 950 950. Paracetamol apollo +9191 46 950 950. Paracetamol
Paracetamol apollo +9191 46 950 950 Paracetamol apollo +9191 46 950 950 Paracetamol CAS Number : 103-90-2 Molecular Weight : 151.17 g/mol Molecular Formula : C8H9NO2 Systematic (IUPAC) : N-(4- hydroxyphenyl)ethanamide
QUESTIONS TO ASK MY DOCTOR
Be a part of the treatment decision by asking questions QUESTIONS TO ASK MY DOCTOR FOR PATIENTS WITH ADVANCED STOMACH OR GASTROESOPHAGEAL JUNCTION (GEJ) CANCER CYRAMZA (ramucirumab) is used alone or in
Share the important information in this Medication Guide with members of your household.
MEDICATION GUIDE BUPRENORPHINE (BUE-pre-NOR-feen) Sublingual Tablets, CIII IMPORTANT: Keep buprenorphine sublingual tablets in a secure place away from children. Accidental use by a child is a medical
Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules
Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules Read this Medication Guide before you start taking EQUETRO and each time you get a refill. There may be new information. This
Roswell Ear, Nose, Throat, & Allergy 342 W. Sherrill Lane Suite A, Roswell, New Mexico 88201 (575)-622-2911 Fax: (575)-622-2598
Roswell Ear, Nose, Throat, & Allergy 342 W. Sherrill Lane Suite A, Roswell, New Mexico 88201 (575)-622-2911 Fax: (575)-622-2598 Patient Registration Form: (Please Print all Pertinent Information) Last
St. Luke s MS Center New Patient Questionnaire. Name: Date: Birth date: Right or Left handed? Who is your Primary Doctor?
St. Luke s MS Center New Patient Questionnaire Name: Date: Birth date: Right or Left handed? Who is your Primary Doctor? Who referred you to the MS Center? List any other doctors you see: Reason you have
SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D]
SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D] I. Definitions: Detoxification is the process of interrupting the momentum of compulsive drug and/or alcohol use in an individual
NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
Diabetic ketoacidosis in children and young people bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They
PATIENT MEDICATION INFORMATION
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr CYRAMZA ramucirumab Read this carefully before you receive CYRAMZA (pronounced "si ram - ze"). This leaflet is a
MEDICATION GUIDE. PROCRIT (PRO KRIT) (epoetin alfa)
MEDICATION GUIDE PROCRIT (PROKRIT) (epoetin alfa) Read this Medication Guide: before you start PROCRIT. if you are told by your healthcare provider that there is new information about PROCRIT. if you are
Thioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid
Package Leaflet: Information for the User Thioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid For use in adults Active substance: Alpha-lipoic acid, Trometamol salt (1:1) Read all
Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200
GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung
Update and Review of Medication Assisted Treatments
Update and Review of Medication Assisted Treatments for Opiate and Alcohol Use Disorders Richard N. Whitney, MD Medical Director Addiction Services Shepherd Hill Newark, Ohio Medication Assisted Treatment
Disease Modifying Therapies for MS
Disease Modifying Therapies for MS The term disease-modifying therapy (DMT) means a drug that can modify or change the course of a disease. In other words a DMT should be able to reduce the number of attacks
It is important that you tell your family and the people closest to you of this increased sensitivity to opioids and the risk of overdose.
MEDICATION GUIDE VIVITROL (viv-i-trol) (naltrexone for extended-release injectable suspension) Read this Medication Guide before you start receiving VIVITROL injections and each time you receive an injection.
Acquired, Drug-Induced Long QT Syndrome
Acquired, Drug-Induced Long QT Syndrome A Guide for Patients and Health Care Providers Sudden Arrhythmia Death Syndromes (SADS) Foundation 508 E. South Temple, Suite 202 Salt Lake City, Utah 84102 800-STOP
UBISTESIN 1:200,000 and UBISTESIN FORTE 1:100,000
UBISTESIN 1:200,000 and UBISTESIN FORTE 1:100,000 Articaine hydrochloride and adrenaline hydrochloride Consumer Medicine Information WHAT IS IN THIS LEAFLET Please read this leaflet carefully before you
What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide
For Patients What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide Patients: Your doctor or nurse will go over this patient guide with you. It is important to ask any questions
SOUTH TAMPA MULTIPLE SCLEROSIS CENTER
SOUTH TAMPA MULTIPLE SCLEROSIS CENTER PATIENT/CARE GIVER QUESTIONNAIRE DEMOGRAPHIC INFORMATION Patient's Name: City: State: Zip Code: Phone: Marital Status: Spouse/Care Giver Name: Phone (H) (W) Occupation:
Disease Modifying Therapies for MS
Disease Modifying Therapies for MS The term disease-modifying therapy means a drug that can modify or change the course of a disease. In other words a DMT should be able to reduce the number of attacks
ICD-10-CM Official Guidelines for Coding and Reporting
2013 Narrative changes appear in bold text Items underlined have been moved within the guidelines since the 2012 version Italics are used to indicate revisions to heading changes The Centers for Medicare
Anaphylaxis. Exceptional healthcare, personally delivered
Anaphylaxis Exceptional healthcare, personally delivered 2 Introduction Anaphylaxis (also known as anaphylactic shock) is a severe, potentially fatal allergic reaction. Anaphylaxis is caused by your body
1g cream or ointment contains 1 mg methylprednisolone aceponate.
CONSUMER MEDICINE INFORMATION ADVANTAN 1g cream or ointment contains 1 mg methylprednisolone aceponate. What is in this leaflet Please read this leaflet carefully before you start using ADVANTAN. It will
Dallas Neurosurgical and Spine Associates, P.A Patient Health History
Dallas Neurosurgical and Spine Associates, P.A Patient Health History DOB: Date: Reason for your visit (Chief complaint): Past Medical History Please check corresponding box if you have ever had any of
Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU
FOR MS RELAPSES Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU As a person with multiple sclerosis (MS), you know firsthand the profound impact MS relapses can have on your
Facts About Chickenpox and Shingles for Adults
Facts About Chickenpox and Shingles for Adults What is chickenpox? Chickenpox, also known as varicella, is a very contagious disease caused by the varicella-zoster virus. It is spread easily through the
Pregnancy and Substance Abuse
Pregnancy and Substance Abuse Introduction When you are pregnant, you are not just "eating for two." You also breathe and drink for two, so it is important to carefully consider what you put into your
PHARMACIST DETACH HERE AND GIVE TO PATIENT
PHARMACIST DETACH HERE AND GIVE TO PATIENT MEDICATION GUIDE HORIZANT (ho-ri' zant) (gabapentin enacarbil) Extended-Release Tablets Read this Medication Guide before you start taking HORIZANT and each time
Low Molecular Weight Heparin. All Wales Medicines Strategy Group (AWMSG) Recommendations and advice
Low Molecular Weight Heparin All Wales Medicines Strategy Group (AWMSG) Recommendations and advice Starting Point Low Molecular Weight Heparin (LMWH): Inhibits factor Xa and factor IIa (thrombin) Small
FAQs on Influenza A (H1N1-2009) Vaccine
FAQs on Influenza A (H1N1-2009) Vaccine 1) What is Influenza A (H1N1-2009) (swine flu) 1? Influenza A (H1N1-2009), previously known as "swine flu", is a new strain of influenza virus that spreads from
Elements for a public summary. VI.2.1 Overview of disease epidemiology. VI.2.2 Summary of treatment benefits
VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Pain is one of the most common reasons for a patient to seek medical attention. Moderate or severe intensity pain can be acute
Consent for Treatment/Procedure Laparoscopic Sleeve Gastrectomy
Patient's Name: Today's Date: / / The purpose of this document is to confirm, in the presence of witnesses, your informed request to have Surgery for obesity. You are asked to read the following document
Anaphylaxis and other adverse events
Anaphylaxis and other adverse events Aim: To be able to manage anaphylaxis and other adverse events correctly Learning outcomes Define local and systemic adverse events Distinguish between anaphylaxis
Biologic Treatments for Rheumatoid Arthritis
Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been
Breast Cancer. Breast Cancer Page 1
Breast Cancer Summary Breast cancers which are detected early are curable by local treatments. The initial surgery will give the most information about the cancer; such as size or whether the glands (or
Introduction to Homeopathic Medicine for the Pharmacy Professional Posttest/Rationale
Introduction to Homeopathic Medicine for the Pharmacy Professional Posttest/Rationale 1. Homeopathic medicines are regulated by the U.S. Food and Drug Administration (FDA) under the A. Affordable Care
Cardiovascular diseases. pathology
Cardiovascular diseases pathology Atherosclerosis Vascular diseases A disease that results in arterial wall thickens as a result of build- up of fatty materials such cholesterol, resulting in acute and
Emergency Room Treatment of Psychosis
OVERVIEW The term Lewy body dementias (LBD) represents two clinical entities dementia with Lewy bodies (DLB) and Parkinson s disease dementia (PDD). While the temporal sequence of symptoms is different
Multiple sclerosis disease-modifying drugs second line treatments
Great Ormond Street Hospital for Children NHS Foundation Trust: Information for Families Multiple sclerosis disease-modifying drugs second line treatments The following information should be read in conjunction
Questions and answers on serious non-fatal adverse events and reporting rules
18 April 2013 EMA/CVMP/PhVWP/303762/2012 Committee for Medicinal Products for Veterinary Use Questions and answers on serious non-fatal adverse events and reporting rules This question and answer document
Safety of HPV vaccination: A FIGO STATEMENT
Safety of HPV vaccination: A FIGO STATEMENT July, 2013 Human papillomavirus vaccines are used in many countries; globally, more than 175 million doses have been distributed. Extensive pre- and post-licensure
INITIATING ORAL AUBAGIO (teriflunomide) THERAPY
FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been
Other Causes of Fever
T e c h n i c a l S e m i n a r s Other Causes of Fever Febrile Illness Causes Fever After Seven Days Referral Relapsing Fever - Borreliosis Overview JHR Adaptation Sore Throat Overview Prevention Management
Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners
Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners Questions and Answers May 2014 Health Protection Scotland
Teriflunomide (Aubagio) 14mg once daily tablet
Teriflunomide (Aubagio) 14mg once daily tablet Exceptional healthcare, personally delivered Your Consultant Neurologist has suggested that you may benefit from treatment with Teriflunomide. The decision
Adjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.
Shared Care Guideline for Prescription and monitoring of Naltrexone Hydrochloride in alcohol dependence Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist,
Streptococcal Infections
Streptococcal Infections Introduction Streptococcal, or strep, infections cause a variety of health problems. These infections can cause a mild skin infection or sore throat. But they can also cause severe,
Topical Tacrolimus or Pimecrolimus for the treatment of mild, moderate or severe atopic eczema. Effective Shared Care Agreement
Topical Tacrolimus or Pimecrolimus for the treatment of mild, moderate or severe atopic eczema. Effective Shared Care Agreement A Copy of this page signed by all three parties should be retained in the
MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets
MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets Read this Medication Guide carefully before you start taking KOMBIGLYZE XR and each time you get
I B2.4. Design of the patient information leaflet for VariQuin
(English translation of official Dutch version) I B2.4. Design of the patient information leaflet for VariQuin Information for the Patient: Read this package leaflet carefully when you have some time to
TdaP-Booster (tee-dee-ay-pee boo-ster)
New Zealand Consumer Medicine Information TdaP-Booster (tee-dee-ay-pee boo-ster) Tetanus, diphtheria and pertussis (acellular mono-component) vaccine (adsorbed, reduced antigen content) CONSUMER MEDICINE
Parents and Grandparents
Parents and Grandparents Vaccination for parents and grandparents is vital to help protect newborn babies against whooping cough. Protect your baby by being immunised too. To find out more about Boostrix
Hospice and Palliative Medicine
Hospice and Palliative Medicine Maintenance of Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills
Remove this cover sheet before redistributing and replace it with your own. Please ensure that DPHHS is included on your HAN distribution list.
State of Montana Health Alert Network DPHHS HAN ADVISORY Cover Sheet DATE: May 15, 2012 SUBJECT: Pertussis INSTRUCTIONS: DISTRIBUTE to your local HAN contacts. This HAN is intended for general sharing
PACKAGE LEAFLET: INFORMATION FOR THE USER. ADRENALINE (HCl) STEROP 0,8mg/1ml. Solution for injection. Adrenaline (Levorenine, Epinephrine)
PACKAGE LEAFLET: INFORMATION FOR THE USER ADRENALINE (HCl) STEROP 0,4mg/1ml ADRENALINE (HCl) STEROP 0,8mg/1ml Solution for injection Adrenaline (Levorenine, Epinephrine) Read all of this leaflet carefully
Severe rheumatoid arthritis (a disease that causes inflammation of the joints),where MabThera is given intravenously together with methotrexate.
EMA/614203/2010 EMEA/H/C/000165 EPAR summary for the public rituximab This is a summary of the European public assessment report (EPAR) for. It explains how the Committee for Medicinal Products for Human
Maintenance of abstinence in alcohol dependence
Shared Care Guideline for Prescription and monitoring of Acamprosate Calcium Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist, Alcohol Services Dr Donnelly
ACLS Cardiac Arrest Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767
ACLS Cardiac Arrest Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767 Copyright 2010 American Heart Association ACLS Cardiac Arrest Circular Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767
A ragweed pollen as a treatment for a ragweed allergy? It s called immunotherapy.
A ragweed pollen as a treatment for a ragweed allergy? It s called immunotherapy. RAGWITEK is a prescription medicine used for sublingual (under the tongue) immunotherapy to treat ragweed pollen allergies
Disclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics
Mitzi Joi Williams, MD Neurologist MS Center of Atlanta, Atlanta, GA Disclosures Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics
Hepatitis C treatment What to expect.
Hepatitis C treatment What to expect. Anne Glass Hepatitis Clinical Nurse Consultant Liver Clinic SSWAHS Bankstown and Liverpool Hospital Contact 87384074 Monday -Friday What s hepatitis? Hepatitis means
Anticoagulant therapy
Anticoagulation: The risks Anticoagulant therapy 1990 2002: 600 incidents reported 120 resulted in death of patient 92 deaths related to warfarin usage 28 reports related to heparin usage Incidents in
MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets
MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets Read this Medication Guide carefully before you start using WELLBUTRIN and each time you get a refill. There may be new information.
COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON HYPERICUM PERFORATUM L., HERBA (TRADITIONAL USE)
European Medicines Agency Evaluation of Medicines for Human Use London, 12 November 2009 Doc. Ref.: EMEA/HMPC/745582/2009 COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH
Immunization Healthcare Branch. Meningococcal Vaccination Program Questions and Answers. Prepared by
Immunization Healthcare Branch Meningococcal Vaccination Program Questions and Answers Prepared by Immunization Healthcare Branch (IHB), Defense Health Agency Last Updated: 27 Mar 06 www.vaccines.mil 877-GET-VACC
Oxford University Hospitals. NHS Trust. Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis. Information for patients
Oxford University Hospitals NHS Trust Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis Information for patients page 2 What is Natalizumab and what is it used for? Natalizumab is an
EMEA PUBLIC STATEMENT ON LEFLUNOMIDE (ARAVA) - SEVERE AND SERIOUS HEPATIC REACTIONS -
The European Agency for the Evaluation of Medicinal Products Post-authorisation evaluation of medicines for human use London, 12 March 2001 Doc. Ref: EMEA/H/5611/01/en EMEA PUBLIC STATEMENT ON LEFLUNOMIDE
Human Normal Immunoglobulin Solution for Intravenous Infusion.
CONSUMER MEDICINE INFORMATION (CMI) OCTAGAM Human Normal Immunoglobulin Solution for Intravenous Infusion. OCTAGAM is available in single use bottles of 20 ml, 50 ml, 100 ml and 200 ml. OCTAGAM contains
Biogen Idec Contacts: Media: Amy Brockelman (617) 914-6524 Investor: Eric Hoffman (617) 679-2812
NEWS RELEASE Media: Nikki Levy (650) 225-1729 Investor: Susan Morris (650) 225-6523 Biogen Idec Contacts: Media: Amy Brockelman (617) 914-6524 Investor: Eric Hoffman (617) 679-2812 GENENTECH AND BIOGEN
University College Hospital. Contrast agent for radiotherapy CT (computed tomography) scans. Radiotherapy Department Patient information series
University College Hospital Contrast agent for radiotherapy CT (computed tomography) scans Radiotherapy Department Patient information series 11 2 If you need a large print, audio or translated copy of
Patient Medication Guide Brochure
Patient Medication Guide Brochure 1 MEDICATION GUIDE TASIGNA (ta-sig-na) (nilotinib) Capsules Read this Medication Guide before you start taking TASIGNA and each time you get a refill. There may be new
Anaphylaxis: a severe, life threatening allergic reaction usually involving swelling, trouble breathing, and can progress to shock
Allergy is a condition in which the immune system causes sneezing, itching, rashes, and wheezing, or sometimes even life-threatening allergic reactions. The more you know about allergies, the better prepared
SECTION N: MEDICATIONS. N0300: Injections. Item Rationale Health-related Quality of Life. Planning for Care. Steps for Assessment. Coding Instructions
SECTION N: MEDICATIONS Intent: The intent of the items in this section is to record the number of days, during the last 7 days (or since admission/reentry if less than 7 days) that any type of injection,
Sepsis Awareness Month
Aon Kenya Insurance Brokers Ltd Aon Hewitt Healthcare Division Sepsis Awareness Month Issue 11 September 2015 In this Issue 2 Getting to understand Sepsis 3 Stages in Sepsis Advancement 4 Diagnosis & Treatment
Summary of the risk management plan (RMP) for Aripiprazole Pharmathen (aripiprazole)
EMA/303592/2015 Summary of the risk management plan (RMP) for Aripiprazole Pharmathen (aripiprazole) This is a summary of the risk management plan (RMP) for Aripiprazole Pharmathen, which details the measures
MEDICATION GUIDE. These serious side effects are described below:
MEDICATION GUIDE LYRICA (LEER-i-kah) (pregabalin) Capsules and Oral Solution, CV Read this Medication Guide before you start taking LYRICA and each time you get a refill. There may be new information.
Medication Guide TASIGNA (ta-sig-na) (nilotinib) Capsules
Medication Guide TASIGNA (ta-sig-na) (nilotinib) Capsules Read this Medication Guide before you start taking Tasigna and each time you get a refill. There may be new information. This information does
